SAMRIDH 2.0 Investment & Paris Ambition India Delegation
Scaling the Architecture of Trust from C-CAMP to Europe
This year kicked off with an earnest "vote of confidence." Cellverse Private Limited is thrilled to announce a $150,000+ investment under SAMRIDH 2.0 from MeitY Startup Hub and Centre for Cellular and Molecular Platforms (C-CAMP). Thanks to MeitY for the heavy lifting of backing foundational "Good Tech". This momentum was carried straight into the heart of Europe, walking through Paris with the FICCI, Invest India, and Business France AMBITION INDIA 2026 delegation celebrating the India-France Year of Innovation.
At the Chambre de Commerce et d'Industrie Franco Indienne (CCIFI) Reception, Nivruti Rai (MD & CEO of Invest India) articulated that India is moving past "capital scarcity" toward Capital Augmentation and Sustainable ROI. The focus is now on a robust plan of returns that builds long-term capability in volatile markets.
Key Highlights & Takeaways
- ✓Investment under SAMRIDH 2.0 by MeitY Startup Hub and C-CAMP.
- ✓Showcase of Intelligent Pathology Systems (digital twins of human diseases) and Data Governance Platforms.
- ✓Bilateral FTA Roundtables led by Invest India CEO Nivruti Rai, CCIFI, and business leaders.
“Indian VCs aren't just funding 'faster croissant delivery' anymore; they are channeling patient capital into deep-tech frontiers. This shift allows founders to view international markets as arenas for strategic growth rather than just a hunt for survival capital.”
Collaborators & Tags
Embassy of India Paris · CCIFI · iStart Rajasthan · Startup India · Piyush Goyal · Sumeet Jarangal · Sanjiv Singh